Ramaswamy Vivek 13D and 13G filings for Roivant Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:46 pm Unchanged |
2023-12-31 | 13G | Roivant Sciences Ltd. ROIV |
Ramaswamy Vivek | 81,454,521 9.750% |
0 (Unchanged) |
Filing |
| 2024-02-13 5:26 pm Sale |
2023-12-31 | 13G | Roivant Sciences Ltd. ROIV |
Ramaswamy Vivek | 81,454,521 9.750% |
-328,720 (-0.40%) |
Filing |
| 2023-02-14 5:20 pm Purchase |
2022-12-31 | 13G | Roivant Sciences Ltd. ROIV |
Ramaswamy Vivek | 81,783,241 10.900% |
7,381,272 (+9.92%) |
Filing |
| 2022-02-14 4:01 pm Purchase |
2021-12-31 | 13G | Roivant Sciences Ltd. ROIV |
Ramaswamy Vivek | 74,401,969 10.500% |
74,401,969 (New Position) |
Filing |